Remarkably, the expression of Tspan5 is closely associated with some clinicopathological features including tumour size, invasive depth, lymph node metastasis and TNM stage and inversely correlated with overall survival of GC patients. This evidence concerns the gene TSPAN5 and gastric cancer.